(PDF) P3.01-82 Survival Impact of Surgery in the Treatment

P3.01-82 Survival Impact of Surgery in the Treatment of Stage IIIB-IVA Non-Small Cell Lung Cancer

Journal of Thoracic Oncology - United States

doi 10.1016/j.jtho.2018.08.1642

Full Text

Abstract

Available in full text

Categories

Respiratory Medicine

Date

October 1, 2018

Authors

Publisher

Elsevier BV

Related search

Survival After Surgery in Stage IA and IB Non–Small Cell Lung Cancer

American Journal of Respiratory and Critical Care Medicine

Respiratory Medicine

Intensive Care Medicine

English

Social Factors, Treatment, and Survival in Early-Stage Non-Small Cell Lung Cancer.

American Journal of Public Health

Occupational Health

English

P3.01-89 Upfront Surgery Versus Neoadjuvant Treatment Followed by Surgery in Pathologic N2 Non-Small Cell Lung Cancer

Journal of Thoracic Oncology

Respiratory Medicine

English

A Nomogram to Predict the Survival of Stage IIIA-N2 Non-Small Cell Lung Cancer After Surgery

Journal of Thoracic and Cardiovascular Surgery

Respiratory Medicine

Cardiovascular Medicine

English

P3.01-05 Mature Progression-Free Survival in Stage IV Non-Small Cell Lung Cancer Patients Treated With Pemetrexed Maintenance Therapy

Journal of Thoracic Oncology

Respiratory Medicine

English

P3.01-40 Treatment of Super Elderly Patients for Non-Small Cell Lung Cancer in Japan

Journal of Thoracic Oncology

Respiratory Medicine

English

Durvalumab for Non-Resectable Stage IIIB Non-Small Cell Lung Cancer—a Small Step or a Big Leap?

Translational Lung Cancer Research

English

P3.01-95 EGFR Genotype as a Predictor of Survival in EGFR Mutant Non-Small Cell Lung Cancer

Journal of Thoracic Oncology

Respiratory Medicine

English

P1.17-02 Low Prognostic Nutritional Index Predicts Poor Survival in Stage IIIB Non-Small Cell Lung Cancer Patients Treated With Chemoradiotherapy

Journal of Thoracic Oncology

Respiratory Medicine

English